Literature DB >> 16467163

Bacteraemia caused by Anaerotruncus colihominis and emended description of the species.

S K P Lau1, P C Y Woo, G K S Woo, A M Y Fung, A H Y Ngan, Y Song, C Liu, P Summanen, S M Finegold, K Yuen.   

Abstract

BACKGROUND: Anaerotruncus colihomonis is a newly described bacterial genus and species isolated from the stool specimens of children. Its clinical significance, however, is unknown. AIMS: To describe a case of A colihominis bacteraemia identified by 16S ribosomal RNA (rRNA) gene sequencing and provide an emended description of the species.
METHODS: An unidentified anaerobic bacillus (strain HKU19) that stains Gram negative was subjected to characterisation by 16S rRNA gene sequencing, G+C content determination and electron microscopy.
RESULTS: Strain HKU19 was isolated from the blood culture of a 78-year-old woman with nosocomial bacteraemia. It was found to be an anaerobic, non-motile, pleomorphic, thin bacillus that stains Gram negative. It produces Indole and utilises glucose and mannose. Identifying the strain to the species level was not possible by conventional phenotypic tests and commercial identification systems. The G+C content of strain HKU19 was found to be 53.43 mol%. A similarity of 99.3% nucleotide identities was found between the 16S rRNA gene sequence of strain HKU19 and that of A colihominis WAL 14 565(T), which was isolated from a human faecal specimen. In contrast with the original description of A colihominis, HKU19 was found to produce occasional oval, terminal spores, although the other phenotypic characteristics matched. Spores were also occasionally observed when the two previously reported strains were re-examined.
CONCLUSIONS: Although the source of the bacteraemia in the patient cannot be determined, this report suggests that A colihominis is of clinical significance. Spore formation is proposed as an emended description of A colihominis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467163      PMCID: PMC1860411          DOI: 10.1136/jcp.2005.031773

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Laribacter hongkongensis gen. nov., sp. nov., a novel gram-negative bacterium isolated from a cirrhotic patient with bacteremia and empyema.

Authors:  K Y Yuen; P C Woo; J L Teng; K W Leung; M K Wong; S K Lau
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens.

Authors:  D A Relman; J S Loutit; T M Schmidt; S Falkow; L S Tompkins
Journal:  N Engl J Med       Date:  1990-12-06       Impact factor: 91.245

3.  Streptococcus sinensis sp. nov., a novel species isolated from a patient with infective endocarditis.

Authors:  Patrick C Y Woo; Dorothy M W Tam; Kit-Wah Leung; Susanna K P Lau; Jade L L Teng; Michelle K M Wong; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

5.  Identification by 16S rRNA gene sequencing of Lactobacillus salivarius bacteremic cholecystitis.

Authors:  Patrick C Y Woo; Ami M Y Fung; Susanna K P Lau; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

6.  Actinomyces hongkongensis sp. nov. a novel Actinomyces species isolated from a patient with pelvic actinomycosis.

Authors:  Patrick C Y Woo; Ami M Y Fung; Susanna K P Lau; Jade L L Teng; Beatrice H L Wong; Michelle K M Wong; Edmund Hon; Grace W K Tang; Kwok-Yung Yuen
Journal:  Syst Appl Microbiol       Date:  2003-11       Impact factor: 4.022

7.  Eggerthella hongkongensis sp. nov. and eggerthella sinensis sp. nov., two novel Eggerthella species, account for half of the cases of Eggerthella bacteremia.

Authors:  Susanna K P Lau; Patrick C Y Woo; Gibson K S Woo; Ami M Y Fung; Michelle K M Wong; King-Man Chan; Dorothy M W Tam; Kwok-Yung Yuen
Journal:  Diagn Microbiol Infect Dis       Date:  2004-08       Impact factor: 2.803

8.  Identification of the uncultured bacillus of Whipple's disease.

Authors:  D A Relman; T M Schmidt; R P MacDermott; S Falkow
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

9.  The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations.

Authors:  M D Collins; P A Lawson; A Willems; J J Cordoba; J Fernandez-Garayzabal; P Garcia; J Cai; H Hippe; J A Farrow
Journal:  Int J Syst Bacteriol       Date:  1994-10

10.  Anaerotruncus colihominis gen. nov., sp. nov., from human faeces.

Authors:  Paul A Lawson; Yuli Song; Chengxu Liu; Denise R Molitoris; Marja-Liisa Vaisanen; Matthew D Collins; Sydney M Finegold
Journal:  Int J Syst Evol Microbiol       Date:  2004-03       Impact factor: 2.747

View more
  13 in total

1.  Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice.

Authors:  Hannah Grazul; L Leann Kanda; David Gondek
Journal:  Gut Microbes       Date:  2016-03-10

2.  Shifts in the Gut Microbiota Composition Due to Depleted Bone Marrow Beta Adrenergic Signaling Are Associated with Suppressed Inflammatory Transcriptional Networks in the Mouse Colon.

Authors:  Tao Yang; Niousha Ahmari; Jordan T Schmidt; Ty Redler; Rebeca Arocha; Kevin Pacholec; Kacy L Magee; Wendi Malphurs; Jennifer L Owen; Gregory A Krane; Eric Li; Gary P Wang; Thomas W Vickroy; Mohan K Raizada; Christopher J Martyniuk; Jasenka Zubcevic
Journal:  Front Physiol       Date:  2017-04-12       Impact factor: 4.566

3.  Influence of Leptin and Adiponectin Supplementation on Intraepithelial Lymphocyte and Microbiota Composition in Suckling Rats.

Authors:  Blanca Grases-Pintó; Mar Abril-Gil; Margarida Castell; Maria J Rodríguez-Lagunas; Stephen Burleigh; Frida Fåk Hållenius; Olena Prykhodko; Francisco J Pérez-Cano; Àngels Franch
Journal:  Front Immunol       Date:  2019-10-09       Impact factor: 7.561

4.  Identification of mucin degraders of the human gut microbiota.

Authors:  Stefano Raimondi; Eliana Musmeci; Francesco Candeliere; Alberto Amaretti; Maddalena Rossi
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

5.  The SHOCT domain: a widespread domain under-represented in model organisms.

Authors:  Ruth Y Eberhardt; S Josefin Bartholdson; Marco Punta; Alex Bateman
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

6.  Colonic immune suppression, barrier dysfunction, and dysbiosis by gastrointestinal bacillus anthracis Infection.

Authors:  Yaíma L Lightfoot; Tao Yang; Bikash Sahay; Mojgan Zadeh; Sam X Cheng; Gary P Wang; Jennifer L Owen; Mansour Mohamadzadeh
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

7.  An insight into intestinal mucosal microbiota disruption after stroke.

Authors:  Dragana Stanley; Robert J Moore; Connie H Y Wong
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

8.  Comparison of the Luminal and Mucosa-Associated Microbiota in the Colon of Pigs with and without Swine Dysentery.

Authors:  Eric R Burrough; Bailey L Arruda; Paul J Plummer
Journal:  Front Vet Sci       Date:  2017-08-24

9.  Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP.

Authors:  Rodrigo Carvalho; Aline Vaz; Felipe Luiz Pereira; Fernanda Dorella; Eric Aguiar; Jean-Marc Chatel; Luis Bermudez; Philippe Langella; Gabriel Fernandes; Henrique Figueiredo; Aristóteles Goes-Neto; Vasco Azevedo
Journal:  Sci Rep       Date:  2018-10-10       Impact factor: 4.379

10.  Fluoxetine-induced alteration of murine gut microbial community structure: evidence for a microbial endocrinology-based mechanism of action responsible for fluoxetine-induced side effects.

Authors:  Mark Lyte; Stephan Schmitz-Esser; Karrie M Daniels
Journal:  PeerJ       Date:  2019-01-09       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.